We, therefore, aimed to investigate its role in osteosarcoma in this study and the interaction with the MIAT carried by osteosarcoma patient serum-derived EVs (EV-MIAT)/miR-613/GPR158 axis to participate in the potential molecular mechanism of Bev in angiogenesis during osteosarcoma. Here, GPR158 is linked to osteosarcoma.